HM30181AK tablet + Irinotecan tablets

DRUG2 trials

Sponsors

Hanmi Pharmaceutical Company Limited

Conditions

Advanced Solid Malignancies

Phase 1

Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies

CompletedNCT00979563

Hanmi Pharmaceutical Company LimitedAdvanced Solid Malignancies

Start: 2008-07-31End: 2010-11-30Updated: 2011-12-07

Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)

CompletedNCT00986843

Hanmi Pharmaceutical Company LimitedAdvanced Solid Malignancies

Start: 2008-06-30End: 2012-09-30Updated: 2013-04-05